chr2-178535858-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong

The NM_001267550.2(TTN):​c.100766-9C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0019 ( 0 hom., cov: 30)
Exomes 𝑓: 0.0022 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

TTN
NM_001267550.2 intron

Scores

2
Splicing: ADA: 0.001820
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.467

Publications

1 publications found
Variant links:
Genes affected
TTN (HGNC:12403): (titin) This gene encodes a large abundant protein of striated muscle. The product of this gene is divided into two regions, a N-terminal I-band and a C-terminal A-band. The I-band, which is the elastic part of the molecule, contains two regions of tandem immunoglobulin domains on either side of a PEVK region that is rich in proline, glutamate, valine and lysine. The A-band, which is thought to act as a protein-ruler, contains a mixture of immunoglobulin and fibronectin repeats, and possesses kinase activity. An N-terminal Z-disc region and a C-terminal M-line region bind to the Z-line and M-line of the sarcomere, respectively, so that a single titin molecule spans half the length of a sarcomere. Titin also contains binding sites for muscle associated proteins so it serves as an adhesion template for the assembly of contractile machinery in muscle cells. It has also been identified as a structural protein for chromosomes. Alternative splicing of this gene results in multiple transcript variants. Considerable variability exists in the I-band, the M-line and the Z-disc regions of titin. Variability in the I-band region contributes to the differences in elasticity of different titin isoforms and, therefore, to the differences in elasticity of different muscle types. Mutations in this gene are associated with familial hypertrophic cardiomyopathy 9, and autoantibodies to titin are produced in patients with the autoimmune disease scleroderma. [provided by RefSeq, Feb 2012]
TTN-AS1 (HGNC:44124): (TTN antisense RNA 1) This gene encodes a non-coding RNA transcribed from the opposite strand to the titin gene. [provided by RefSeq, Aug 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 2-178535858-G-A is Benign according to our data. Variant chr2-178535858-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 47631.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TTNNM_001267550.2 linkc.100766-9C>T intron_variant Intron 357 of 362 ENST00000589042.5 NP_001254479.2 A0A0A0MTS7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TTNENST00000589042.5 linkc.100766-9C>T intron_variant Intron 357 of 362 5 NM_001267550.2 ENSP00000467141.1 A0A0A0MTS7

Frequencies

GnomAD3 genomes
AF:
0.00191
AC:
199
AN:
104304
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00161
Gnomad AMI
AF:
0.00332
Gnomad AMR
AF:
0.000908
Gnomad ASJ
AF:
0.000754
Gnomad EAS
AF:
0.000521
Gnomad SAS
AF:
0.00170
Gnomad FIN
AF:
0.00969
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00155
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0116
AC:
643
AN:
55198
AF XY:
0.0115
show subpopulations
Gnomad AFR exome
AF:
0.0131
Gnomad AMR exome
AF:
0.00962
Gnomad ASJ exome
AF:
0.0134
Gnomad EAS exome
AF:
0.00803
Gnomad FIN exome
AF:
0.0190
Gnomad NFE exome
AF:
0.0118
Gnomad OTH exome
AF:
0.00813
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00220
AC:
2489
AN:
1129796
Hom.:
0
Cov.:
27
AF XY:
0.00253
AC XY:
1403
AN XY:
553568
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00396
AC:
101
AN:
25498
American (AMR)
AF:
0.00895
AC:
184
AN:
20568
Ashkenazi Jewish (ASJ)
AF:
0.00303
AC:
54
AN:
17796
East Asian (EAS)
AF:
0.00344
AC:
116
AN:
33748
South Asian (SAS)
AF:
0.00938
AC:
517
AN:
55126
European-Finnish (FIN)
AF:
0.00579
AC:
194
AN:
33496
Middle Eastern (MID)
AF:
0.00652
AC:
27
AN:
4144
European-Non Finnish (NFE)
AF:
0.00137
AC:
1218
AN:
891584
Other (OTH)
AF:
0.00163
AC:
78
AN:
47836
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.297
Heterozygous variant carriers
0
193
386
579
772
965
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00192
AC:
200
AN:
104330
Hom.:
0
Cov.:
30
AF XY:
0.00207
AC XY:
103
AN XY:
49684
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00161
AC:
44
AN:
27334
American (AMR)
AF:
0.000907
AC:
9
AN:
9924
Ashkenazi Jewish (ASJ)
AF:
0.000754
AC:
2
AN:
2654
East Asian (EAS)
AF:
0.000522
AC:
2
AN:
3830
South Asian (SAS)
AF:
0.00171
AC:
6
AN:
3500
European-Finnish (FIN)
AF:
0.00969
AC:
58
AN:
5988
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
198
European-Non Finnish (NFE)
AF:
0.00155
AC:
76
AN:
48882
Other (OTH)
AF:
0.000705
AC:
1
AN:
1418
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.279
Heterozygous variant carriers
0
17
35
52
70
87
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00196
Hom.:
0

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Nov 22, 2011
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

93062-9C>T in intron 306 of TTN: This variant is not expected to have clinical s ignificance because it is located outside the conserved +/- 1, 2 region of the s plicing consensus sequence and as part of a poly T stretch. -

Autosomal recessive limb-girdle muscular dystrophy type 2J Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Benign:1
Mar 18, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Early-onset myopathy with fatal cardiomyopathy Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Tibial muscular dystrophy Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Myopathy, myofibrillar, 9, with early respiratory failure Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
18
DANN
Benign
0.81
PhyloP100
0.47

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0018
dbscSNV1_RF
Benign
0.054
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77483833; hg19: chr2-179400585; API